• Science & Technology

The DETERMINE trial: a timeline to treating the 100th patient

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

28 February 2025

• Health & Medicine

Let's talk about poo

Talking about poo can save lives from bowel cancer. Here are our top poo facts to get the conversation going. Talking about poo can save lives from bowel cancer. Here are our top poo facts to get the conversation going.

24 February 2025

• Health & Medicine
• Science & Technology

Rays of hope: how Cancer Research UK helped shape radiotherapy

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

17 February 2025

• Charity News

Every hour matters: our volunteering highlights from 2024

We’re grateful to benefit from the support of more than 25,000 incredible volunteers, supporters and panel members.  Here, we're taking a look back at some of the varied and inspiring ways that people have given their time to support us this year.  We’re grateful to benefit from the support of more than 25,000 incredible volunteers, supporters and panel members.  Here, we're taking a look back at some of the varied and inspiring ways that people have given their time to support us this year. 

3 December 2024

• Science & Technology
• Health & Medicine
• Policy & Insight

The story of genomics - and our plan for its next chapter

Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK. Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK.

7 November 2024

• Science & Technology
• Health & Medicine

12 ways we’ve influenced progress in lung cancer 

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 12 ways we have worked towards progress in lung cancer.

31 October 2024

• Science & Technology
• Health & Medicine

30 years of BRCA: How the discovery of two breast cancer genes continues to drive progress

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

1 October 2024

• Science & Technology
• Health & Medicine

Children's and young people's cancers: Driving progress for more than 50 years

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

3 September 2024

• Health & Medicine
• Science & Technology

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

8 August 2024

• Health & Medicine
• Policy & Insight

Cancer waiting times: Who are the long waiters? 

We’re seeing a rise in ‘long waiters’ - people who wait for over 104 days to begin their cancer treatment. But who are these long waiters? We’ve recently carried out research in partnership with the National Disease Registration Service (NDRS), part of NHS England, to find out more. We’re seeing a rise in ‘long waiters’ - people who wait for over 104 days to begin their cancer treatment. But who are these long waiters? We’ve recently carried out research in partnership with the National Disease Registration Service (NDRS), part of NHS England, to find out more.

16 July 2024

• For Supporters
• Health & Medicine
• Personal Stories

Maria García: "When you help people to advance knowledge and research, everyone benefits"

A conversation with Maria García, a long-term supporter of Cancer Research UK and the Crick. A conversation with Maria García, a long-term supporter of Cancer Research UK and the Crick.

4 July 2024

• Health & Medicine
• Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

17 June 2024